To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
Tongji Hospital
500 participants
Apr 1, 2025
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to explore the value of new MR technology in assessing the systemic metabolism, disease status, and prognostic risk of metabolism-related fatty liver disease. By obtaining clinical, imaging, laboratory examination and pathological data of metabolism-related fatty liver disease, image processing software is used to analyze the images, explore the relationship between imaging parameters, body composition and metabolic diseases and metabolism-related fatty liver disease, and achieve non-invasive diagnosis, efficacy evaluation, and prognosis prediction of metabolism-related fatty liver disease. Thereby guiding clinical treatment and improving the prognosis and quality of life of patients with metabolism-related fatty liver disease
Eligibility
Inclusion Criteria3
- Patients with MR examination are clinically suspected or diagnosed with metabolism-related fatty liver disease;
- Age/gender: unlimited;
- Patients who voluntarily participate in clinical trials and sign written subject informed consent
Exclusion Criteria2
- Clinical suspicion or diagnosis of metabolism-related fatty liver disease and having been prescribed an MR examination;
- Voluntarily participation in the study and provision of written informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07149571